上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1371Please respect copyright.PENANAgqal0IEa9M
1371Please respect copyright.PENANAVELWAnJSw6
上集:https://www.penana.com/article/4711251371Please respect copyright.PENANAPfFgMcid4X
1371Please respect copyright.PENANA8mKV4bB3vX1371Please respect copyright.PENANACl9BXQjcRJ
1371Please respect copyright.PENANAXJlHQcAsTF
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1371Please respect copyright.PENANAa9EWzX64qf
1371Please respect copyright.PENANAfzCKYmg9yN
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1371Please respect copyright.PENANAJmmkMw06tR
1371Please respect copyright.PENANAT5WrNAC5p6
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1371Please respect copyright.PENANATUARwuWcBY
1371Please respect copyright.PENANAJsNhyxBd3r1371Please respect copyright.PENANANQO2clyKvW
1371Please respect copyright.PENANAvTijrE3kI2
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1371Please respect copyright.PENANA1FiHc3uxPW
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1371Please respect copyright.PENANAThMjLE1eYH
1371Please respect copyright.PENANAxqCWPXDUBq
忘記甚麼是Neoantigen的話,可重溫上一集。1371Please respect copyright.PENANAUiNIwoD2VP
1371Please respect copyright.PENANAPOScJIGleS
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1371Please respect copyright.PENANAoOBKGpSEiS
1371Please respect copyright.PENANAPxmoycXtNj
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1371Please respect copyright.PENANAnVRzdg6aiR
1371Please respect copyright.PENANAfxW55zen0u1371Please respect copyright.PENANAHVIpQIUduD
1371Please respect copyright.PENANARWTgtknfbZ
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1371Please respect copyright.PENANA6zGYoUbBZk
1371Please respect copyright.PENANAbbjGXXZNic
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1371Please respect copyright.PENANAPETTK8w4w0
1371Please respect copyright.PENANAuXRwbjhZxy
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1371Please respect copyright.PENANAzP8bDs4I091371Please respect copyright.PENANAILJ8dP5IKl
1371Please respect copyright.PENANA0IO762cTgU
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1371Please respect copyright.PENANA8DTfRlc4B0
1371Please respect copyright.PENANAjlEKqYU8cB
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1371Please respect copyright.PENANAeaAL4k3vl81371Please respect copyright.PENANApYfMWgPgB0
1371Please respect copyright.PENANATCzb1eG8OD
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1371Please respect copyright.PENANAhuz1xF9aWq
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1371Please respect copyright.PENANAuWX9mls5Mk
1371Please respect copyright.PENANAIqDNeuKtGt
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1371Please respect copyright.PENANAZclRhUzI68
1371Please respect copyright.PENANAhkUXhmqpHk
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1371Please respect copyright.PENANAXkK4wZHzvQ
1371Please respect copyright.PENANAigDi6RvVAy
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1371Please respect copyright.PENANA9SlGz22x4P
1371Please respect copyright.PENANAeciOWeEh7P
1371Please respect copyright.PENANAJpwdiDVT3T
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1371Please respect copyright.PENANAXrnCw5JBJ0
1371Please respect copyright.PENANA3Uicx9kjml
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1371Please respect copyright.PENANAUvrX4qO97l
1371Please respect copyright.PENANA7pZxd7FBOw
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1371Please respect copyright.PENANAPHwNQxxubD
1371Please respect copyright.PENANAzkUhHX6XZP
Link:1371Please respect copyright.PENANAbqDgXddsb4
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1371Please respect copyright.PENANAnnuMsHNOt2
1371Please respect copyright.PENANAHosYfum6S9
1371Please respect copyright.PENANA6kyP4g7Nrh
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1371Please respect copyright.PENANAK8I7B6R9R1